The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis.

Tomoya MitaNaoto KatakamiToshihiko ShiraiwaHidenori YoshiiMasahiko GoshoHitoshi IshiiIichiro ShimomuraHirotaka Watadanull null

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)

Mitsubishi Tanabe Pharma Co., Ono Pharmaceutical Co., and Novo Nordisk.

Keyphrases